Pfizer exec jumps ship to join Biogen

Anabella Villalobos has been appointed as senior vice president, Biotherapeutic & Medicinal Sciences (BTMS), at US biotech major Biogen (Nasdaq: BIIB).

Dr Villalobos will lead Biogen’s BTMS organization in the delivery of high-quality, differentiated molecules to the clinic. She will report to Michael Ehlers, executive vice president, head of research and development.

Dr Villalobos joins Biogen from Pfizer (NYSE: PFE) Worldwide Research and Development, where she most recently served as vice president and head of medicinal synthesis technologies. With over 25 years of industry experience in the areas of neuroscience and medicinal chemistry, she has been instrumental in the development of clinical candidates for Alzheimer’s disease, Parkinson’s disease, schizophrenia and pain.